Forte Biosciences, Inc.

General ticker "FBRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $393.4M (TTM average)

Forte Biosciences, Inc. follows the US Stock Market performance with the rate: 36.0%.

Estimated limits based on current volatility of 6.1%: low 17.63$, high 19.90$

Factors to consider:

  • Total employees count: 67 as of 2017
  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [10.24$, 34.98$]
  • 2026-12-31 to 2027-12-31 estimated range: [5.06$, 19.25$]

Financial Metrics affecting the FBRX estimates:

  • Negative: with PPE of -5.7 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of 0.90 > -0.60
  • Positive: Shareholder equity ratio, % of 73.68 > 64.29
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term FBRX quotes

Long-term FBRX plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $32.49MM $36.60MM $70.66MM
Operating Income $-32.49MM $-36.60MM $-70.66MM
Non-Operating Income $1.01MM $1.12MM $2.32MM
R&D Expense $21.86MM $20.71MM $57.65MM
Income(Loss) $-31.48MM $-35.48MM $-68.34MM
Taxes $0.00MM $0.00MM $1.04MM
Net Income(Loss)* $-31.48MM $-35.48MM $-69.38MM
Stockholders Equity $35.31MM $52.48MM $60.99MM
Assets $38.98MM $61.56MM $82.78MM
Operating Cash Flow $-28.71MM $-30.75MM $-50.88MM
Capital expenditure $0.09MM $0.04MM $0.12MM
Investing Cash Flow $0.05MM $-35.99MM $36.23MM
Financing Cash Flow $24.68MM $51.86MM $69.36MM
Earnings Per Share** $-24.92 $-12.17 $-0.47

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.